𝔖 Bobbio Scriptorium

✦ LIBER ✦

Strontium89 Chloride versus Palliative Local Field Radiotherapy in Patients with Hormonal Escaped Prostate Cancer: A Phase III Study of the European Organisation for Research and Treatment of Cancer Genitourinary Group

✍ Scribed by G.O.N. Oosterhof; J.T. Roberts; Th.M. de Reijke; S.A. Engelholm; S. Horenblas; H. von der Maase; N. Neymark; M. Debois; L. Collette

Book ID: 114218722
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 141 KB
Volume: 44
Category: Article
ISSN: 0302-2838
DOI: 10.1016/s0302-2838(03)00364-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Strontium-89 chloride versus palliative

Strontium-89 chloride versus palliative local field radiotherapy in patients with hormonal escaped prostate cancer: A phase III study of the European organisation for research and treatment of cancer

✍ G. Oosterhof; Roberts; Th.M. De Reijke; Engelholm; S. Horenblas; Von der Maase; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 226 KB

Postoperative adjuvant chemotherapy foll

Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer: A randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast Group

✍ Leilani Morales; Peter Canney; Jaroslaw Dyczka; Emiel Rutgers; Robert Coleman; T 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 201 KB

Phase III randomised study to evaluate t

Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: An European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)

✍ N.S. Reed; C. Mangioni; H. Malmström; G. Scarfone; A. Poveda; S. Pecorelli; S. T 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 370 KB

Corrigendum to “Phase III randomised stu

Corrigendum to “Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: An European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)” [European Journal of Cancer, 44 (2008) 808–818]

✍ N.S. Reed; C. Mangioni; H. Malmström; G. Scarfone; A. Poveda; S. Pecorelli; S. T 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Chemoimmunotherapy with dacarbazine, cis

Chemoimmunotherapy with dacarbazine, cisplatin, interferon-alpha2b and interleukin-2 versus two cycles of dacarbazine followed by chemoimmunotherapy in patients with metastatic melanoma: A randomised phase II study of the European Organization for Research and Treatment of Cancer Melanoma Group

✍ C.J.A. Punt; S. Suciu; M.A. Gore; J. Koller; W.H.J. Kruit; J. Thomas; P. Patel; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Randomized phase II/III trial of interfe

Randomized phase II/III trial of interferon alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell carcinoma: The European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951): Aass N, De Mulder PHM, Mickisch GHJ, Mulders P, van Oosterom AT, van Poppel H, Fossa SD, de Prijck L, Sylvester RJ, Department of Clinical Cancer Research, The Norwegian Radium Hospital, Oslo, Norway

✍ Robert Flanigan 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 42 KB